Status:
COMPLETED
Predictive Value of Dynamic Contrast Enhancement MRI on a Cerebral Tumor Response to Gamma Knife Treatment
Lead Sponsor:
Martin Lepage
Conditions:
Cerebral Metastases
Eligibility:
All Genders
18+ years
Brief Summary
Hypothesis: the pattern of MRI contrast enhancement after gadolinium injection is different in tumors that respond well to gamma knife. We are going to acquire sequential T1-weighted images of brain ...
Eligibility Criteria
Inclusion
- Patient with intracerebral lesion benign or malignant wich are not concerned by the exclusion criteria
Exclusion
- Pancranial radiotherapy
- Residual postop lesion
- Gliomas
- Patients \< 18 years old
- Anterior allergic reaction to gadolinium
- Claustrophobia.
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00156585
Start Date
August 1 2005
End Date
April 1 2008
Last Update
January 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculté de médecine, Université de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4